Skip to main content
SpringerLink
Log in

Results from surgical treatment for thymoma

43 years of experience

  • Original Article
  • Published:
The Japanese Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objective: The biological behavior of thymoma and its prognosis after surgical intervention remain still controversial. The efficacy of surgical treatment for thymoma was investigated by examining long-term follow-up data.Subjects and Methods: Follow-up data for patients undergoing surgical resection of histopathologically-confirmed thymoma between 1954 and 1997 were obtained and were retrospectively analyzed. Clinical staging was based on Masaoka’s staging system, and histological classification on Rosai’s proposed criteria.Results: Data for 140 patients were collected. Sixty-four patients had stage I, 32 had stage II, 28 had stage III, and 16 had stage IV thymoma. There were significant differences in survival between patients with stage I and stage III, stage I and stage IV and stage II and stage III disease, but not between those with stage I thymoma and stage II thymoma. No significant difference in survival was observed between the 56 patients with myasthenia gravis (MG) and the 84 without MG. The 38 patients classified as having a predominantly-epithelial thymoma had a poorer prognosis than the 41 with a predominantly-lymphocytic thymoma. Until 1975, there were four patients with stage I thymomas who later showed recurrence, compared with 21 among those with stage II, III and IV diseases. Since 1976, extended thymectomy with thymomectomy under median sternotomy has been adopted as the standard operation for a thymoma, and there has been no recurrence in stage I patients.Conclusions: Patients with stage III or IV invasive thymoma have a poorer prognosis and a higher recurrence rate than those with encapsulated thymoma, and patients with a predominantly-epithelial thymoma have a poorer prognosis than those with a predominantly-lymphocytic thymoma. Extended thymectomy with thymomectomy under median sternotomy can be considered as adequate treatment for a stage I thymoma. Myasthenia gravis does not appear to affect the prognosis of patients with a thymoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study with special reference to their clinical stages. Cancer 1981; 48: 2485–92.

    Article  PubMed  CAS  Google Scholar 

  2. Rosai J, Levine GD. Thymoma. In: Tumors of the thymus: Atlas of Tumor Pathology, 2nd Series, Fascicle 13. Washington, D.C.: Armed Forces Institute of Pathology, 1976; 34–162.

    Google Scholar 

  3. Marino M, Müller-Hermelink HK. Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch [Pathol Anat] 1985; 407: 119–49.

    Article  CAS  Google Scholar 

  4. Shimosato Y, Mukai K. Thymoma. In: Tumors of the thymus: Atlas of Tumor Pathology, 3rd Series, Fascicle 21. Washington, D.C.: Armed Forces Institute of Pathology, 1997; 40–120.

    Google Scholar 

  5. Quintanilla-Martinez L, Wilkins EW, Choi N, Efird J, Hug E, Harris NL. Thymoma: histologic subclassification is an independent prognostic factor. Cancer 1994; 74: 606–17.

    Article  PubMed  CAS  Google Scholar 

  6. Fujimura S, Kondo T, Handa M, Shiraishi Y, Tamahashi N, Nakada T. Results of surgical treatment for thymoma based on 66 patients. J Thorac Cardiovasc Surg 1987; 93: 708–14.

    PubMed  CAS  Google Scholar 

  7. Wilkins EW, Grillo HC, Scannell JG, Moncure AC, Mathisen DJ. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 1991; 51: 888–92.

    Article  PubMed  Google Scholar 

  8. Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg 1961; 42: 424–44.

    PubMed  CAS  Google Scholar 

  9. Batata MA, Martini N, Huvos AG, Aguilar RI, Beattie EJ. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 1974; 34: 389–96.

    Article  PubMed  CAS  Google Scholar 

  10. Legg MA, Brady WJ. Pathology and clinical behavior of thymomas: a survey of 51 cases. Cancer 1965; 18: 1131–44.

    Article  PubMed  CAS  Google Scholar 

  11. Salyer WR, Eggleston JC. Thymoma: a clinical and pathological study of 65 cases. Cancer 1976; 37: 229–49.

    Article  PubMed  CAS  Google Scholar 

  12. Regnard JF, Magdeleinat P, Dromer C, Dulmet E, Montpreville VD, Levi JF, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996; 112: 376–84.

    Article  PubMed  CAS  Google Scholar 

  13. Pescarmona E, Rendina EA, Venuta F, Arcangelo ED, Pagani M, Ricci C, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 1990; 50: 534–8.

    Article  PubMed  CAS  Google Scholar 

  14. Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y, et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 1985; 39: 165–9.

    Article  PubMed  CAS  Google Scholar 

  15. Regnard JF, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997; 64: 1593–8.

    Article  PubMed  CAS  Google Scholar 

  16. Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavallo A, Cianci R, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997; 113: 55–63.

    Article  PubMed  CAS  Google Scholar 

  17. Nakajima J, Sindou G, Yokoi Y, Saitoh H, Igarasi H, Kondoh H, et al. Recurrence of thymoma in stage I: report of 4 cases. Jpn J Thorac Surg 1988; 41: 19–24.

    CAS  Google Scholar 

  18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.

    Article  Google Scholar 

  19. Venuta F, Rendina EA, Pescarmona EO, Giacomo TD, Vegna ML, Fazi P, et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg 1997; 64: 1585–92.

    Article  PubMed  CAS  Google Scholar 

  20. Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995; 60: 908–14.

    Article  PubMed  CAS  Google Scholar 

  21. Nakahara K, Ohno K, Hasimoto J, Maeda H, Miyoshi S, Sakurai M, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988; 95: 1041–7.

    PubMed  CAS  Google Scholar 

  22. Monden Y, Uyama T, Taniki T, Hashimoto J, Fujii Y, Nakahara K, et al. The characteristics of thymoma with myasthenia gravis: a 28-year experience. J Surg Oncol 1988; 38: 151–4.

    Article  PubMed  CAS  Google Scholar 

  23. Hishima T, Fukuyama M, Fujisawa M, Hayashi Y, Arai K, Funata N, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994; 145: 268–75.

    PubMed  CAS  Google Scholar 

  24. Asamura H, Nakajima T, Mukai K, Noguchi M, Simosato Y. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area: an analysis of 39 cases. Am J Pathol 1988; 133: 615–22.

    PubMed  CAS  Google Scholar 

  25. Masaoka A, Nagaoka Y, Kotake Y. Distribution of thymic tissue at the anterior mediastinum: current procedures in thymectomy. J Thorac Cardiovasc Surg 1975; 70: 747–54.

    PubMed  CAS  Google Scholar 

  26. Awad WI, Symmans PJ, Dussek JE. Recurrence of stage I thymoma 32 years after total excision. Ann Thorac Surg 1998; 66: 2106–8.

    Article  PubMed  CAS  Google Scholar 

  27. Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 1991; 68: 706–13.

    Article  PubMed  CAS  Google Scholar 

  28. Rea F, Sartori F, Loy M, Calabrò F, Fornasiero A, Daniele O, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993; 106: 543–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiothoracic Surgery, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan

    Tomohiro Murakawa, Jun Nakajima, Tadasu Kohno, Makoto Tanaka, Jun Matsumoto, Eriho Takeuchi & Shinichi Takamoto

Authors
  1. Tomohiro Murakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tadasu Kohno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Makoto Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eriho Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shinichi Takamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murakawa, T., Nakajima, J., Kohno, T. et al. Results from surgical treatment for thymoma. Jpn J Thorac Caridovasc Surg 48, 89–95 (2000). https://doi.org/10.1007/BF03218097

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03218097

Key words

Search

Navigation